Prostate health is an essential aspect of male well-being, yet many men avoid discussing it—until the symptoms become too severe to ignore. Consider waking up several times at night and hurrying ...
AstraZeneca had a disappointing trial readout with its AKT inhibitor Truqap in breast cancer in June, so unsurprisingly it is trumpeting a first-in-class win for the drug in prostate cancer.